Human α Defensin in HIV-Exposed But Uninfected Individuals
Authors:
- Daria TrabattoniDaria Trabattoni
- Sergio Lo CaputoSCSergio Lo Caputo
- Giada MaffeisGMGiada Maffeis
- Francesca VichiFVFrancesca Vichi
- Mara BiasinMara Biasin
- Piera PierottiPPPiera Pierotti
- Francesca FasanoFFFrancesca Fasano
- Marina SaresellaMarina Saresella
- Mario FranchiniMFMario Franchini
- Pasquale FerrantePasquale Ferrante
- Francesco MazzottaFMFrancesco Mazzotta
- Mario ClericiMario Clerici
- 1 April 2004
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 35 (5) , 455-463
Abstract
Human alpha defensins 1, 2, and 3 are produced by CD8 T cells of HIV-infected long-term nonprogressors and have an antiviral activity. alpha Defensins were examined in peripheral blood mononuclear cells (PBMCs), cervical-vaginal mononuclear cells (CVMCs), and cervical biopsies of 9 HIV-1-exposed but uninfected women (ESNs), 10 HIV-infected patients (HIV), and 13 low-risk healthy controls (HCs). Results showed that, whereas alpha defensin production and alpha defensin-expressing CD8 lymphocytes were comparable in ESNs and HIV patients, constitutive alpha defensin production by peripheral CD8 and CVMCs was augmented in ESNs compared with HCs (P = 0.001 and P = 0.058, respectively); alpha defensin mRNA was increased in PBMCs of ESNs; unstimulated, alpha defensin-expressing peripheral and mucosal CD8 lymphocytes were 10-fold higher in ESNs compared with HCs (P = 0.003 and P = 0.01, respectively); and alpha defensin mRNA and alpha defensin-expressing cells were augmented in cervical biopsies of ESN compared with HCs (mRNA:P = 0.03). The differences were reduced upon in vitro mitogen stimulation. A robust constitutive production of alpha defensin is seen in HIV-exposed uninfected individuals; these peptides could have a role in the potentially protective immune response that characterizes ESNs.Keywords
This publication has 39 references indexed in Scilit:
- Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual menAIDS, 2003
- Cervicovaginal Secretory Antibodies to Human Immunodeficiency Virus Type 1 (HIV‐1) that Block Viral Transcytosis through Tight Epithelial Barriers in Highly Exposed HIV‐1–Seronegative African WomenThe Journal of Infectious Diseases, 2001
- Influence of HLA Supertypes on Susceptibility and Resistance to Human Immunodeficiency Virus Type 1 InfectionThe Journal of Infectious Diseases, 2000
- HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workersAIDS, 1999
- Epidemiologic and Biologic Characterization of a Cohort of Human Immunodeficiency Virus Type 1 Highly Exposed, Persistently Seronegative Female Sex Workers in Northern ThailandThe Journal of Infectious Diseases, 1999
- A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutationNature Medicine, 1998
- HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 geneThe Lancet, 1998
- HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individualsNature Medicine, 1997
- Chemokine Receptors and HIV-1: An Attractive Pair?Cell, 1996
- Relative resistance to HIV–1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high–risk sexual exposuresNature Medicine, 1996